Lincoln Pharmaceuticals
564.90
-4.00(-0.70%)
Market Cap₹1,139.50 Cr
PE Ratio13.77
IndustryHealthcare
Company Performance:
1D-0.70%
1M-2.38%
6M-31.21%
1Y-14.69%
5Y+246.99%
View Company Insightsright
Latest news about Lincoln Pharmaceuticals
Lincoln Pharmaceuticals Completes Trial Run at Khatraj Facility, Eyes API Production 6 days ago
Lincoln Pharmaceuticals has successfully completed the trial run of its Khatraj facility, a key step in its expansion plans. The company aims to commence commercial production of Active Pharmaceutical Ingredients (APIs) at this facility within 1-2 years, subject to regulatory approvals. This move is expected to enhance manufacturing capabilities, potentially leading to vertical integration, cost efficiency, improved quality control, and stronger market positioning.